Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03245489
What this trial is testing

Anti-platelet + Pembro for H&N Tumors

Who this might be right for
Head and Neck Cancer
Medical University of South Carolina 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05044897
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 11
Testing effectiveness (Phase 2)Study completedNCT00006033
What this trial is testing

Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Looking for participantsNCT06016920
What this trial is testing

Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell CarcinomaHNSCC
Nykode Therapeutics ASA 110
Not applicableUnknownNCT03917524
What this trial is testing

Feasibility of CTCs Isolation for Transcriptomes and Genome Wide Associated Analysis in Post-OP High Risk OSCC Patients.

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Chang Gung Memorial Hospital 180
Testing effectiveness (Phase 2)UnknownNCT00004226
What this trial is testing

Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy

Who this might be right for
Head and Neck Cancer
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT04704154
What this trial is testing

A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors

Who this might be right for
Solid Tumors
Bayer 175
Large-scale testing (Phase 3)Not Yet RecruitingNCT07758621
What this trial is testing

SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
CSPC Megalith Biopharmaceutical Co.,Ltd. 340
Testing effectiveness (Phase 2)Looking for participantsNCT07105592
What this trial is testing

Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Fudan University 68
Testing effectiveness (Phase 2)Ended earlyNCT06046482
What this trial is testing

Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma

Who this might be right for
Head NeckSquamous Cell Carcinoma of Head and Neck
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07662720
What this trial is testing

A Phase II Trial for MOR Antagonism With Axelopran to Enhance Immunotherapy in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Glycyx Therapeutics 18
Testing effectiveness (Phase 2)UnknownNCT04398524
What this trial is testing

A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
ISA Pharmaceuticals 65
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Testing effectiveness (Phase 2)UnknownNCT04650633
What this trial is testing

SHR-1701 in Patients With Recurrent/Metastatic Scchn

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Jiangsu HengRui Medicine Co., Ltd. 130
Early research (Phase 1)Study completedNCT06236425
What this trial is testing

TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and NeckMetastatic Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 7
Testing effectiveness (Phase 2)Study completedNCT00268671
What this trial is testing

Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN)

Who this might be right for
Head and Neck Neoplasms
Sanofi 45
Early research (Phase 1)Ended earlyNCT00906360
What this trial is testing

Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+29 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT02643550
What this trial is testing

Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Neoplasms
Innate Pharma 143
Testing effectiveness (Phase 2)Study completedNCT00076310
What this trial is testing

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 50
Next Page